Crowdonomics
This isn’t Jabez Biosciences, Inc.’s most recent raise. Private · Convertible Note · Mar 2026 (Closed) is more current.View latest round
Jabez Biosciences, Inc.

Reg A+ · Equity · Sep 2024

ClosedReg A+Equity
via the platform · last checked Aug 16, 2026
Raised
$38K / $10M max
0% of ceiling
Investors
—
—
Estimated pre-money
$61.4M
—

Financials disclosed in this offering

FY2023 · hover for source
$0
−$13K
FY2023
RevenueNet income
Metric
FY2023 audited
Income statement
Revenue
$0
Cost of goods sold
$0
Net income
-$12,613
Balance sheet
Cash
$12,000
Accounts receivable
$0
Total assets
$12,000
Long-term debt
$22,500
Total liabilities
$22,613
Other
Headcount
1

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

4 amendments
  1. Dec 12, 2024
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  2. Dec 3, 2024
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  3. Nov 20, 2024
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  4. Oct 29, 2024
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$61.4M
Price / share$2.00
Shares offered5,000,000

Estimated, not stated: $2.00 × 30,681,000 securities outstanding.

Offering details

Target—
Max$10,000,000
Min investment—
OpenedSep 23, 2024
Deadline—
ClosedJun 12, 2026
Days active627

Links & provenance

Source: SEC EDGAR
0001213900-24-080792
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.